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The development of constrained peptides for inhibition of protein–protein interactions is an emerging
strategy in chemical biology and drug discovery. This manuscript introduces a versatile, rapid and
reversible approach to constrain peptides in a bioactive helical conformation using BID and RNase S
peptides as models. Dibromomaleimide is used to constrain BID and RNase S peptide sequence variants
bearing cysteine (Cys) or homocysteine (hCys) amino acids spaced at i and i + 4 positions by double
substitution. The constraint can be readily removed by displacement of the maleimide using excess thiol.
This new constraining methodology results in enhanced a-helical conformation (BID and RNase S
peptide) as demonstrated by circular dichroism and molecular dynamics simulations, resistance to
proteolysis (BID) as demonstrated by trypsin proteolysis experiments and retained or enhanced potency
of inhibition for Bcl-2 family protein–protein interactions (BID), or greater capability to restore the
hydrolytic activity of the RNAse S protein (RNase S peptide). Finally, use of a dibromomaleimide
functionalized with an alkyne permits further divergent functionalization through alkyne–azide
cycloaddition chemistry on the constrained peptide with ﬂuorescein, oligoethylene glycol or biotin
groups to facilitate biophysical and cellular analyses. Hence this methodology may extend the scope and
accessibility of peptide stapling.Introduction
Inhibition of a-helix mediated protein–protein interactions
(PPIs)1–4 represents an area of intense interest, due to their role in
intracellular signalling processes5 and demonstrated tractability
for drug discovery.6,7 The last decade has seen an increasing
emphasis on the development of constrained peptides8–10 for PPI
inhibition. Constraint of a peptide in a bioactive conformation is
proposed to improve target binding aﬃnity (by preorganiza-
tion),11,12 increase stability (e.g. by protecting against proteol-
ysis)13–15 and enhance cell-uptake,16,17 although a number of
recent studies have provided conicting evidence for the
enhanced cell permeability and cellular potency that is conferred
through stapling.18–20 Available strategies9,13,21–25 to constrain
a peptide in a helical conformation (Fig. 1a–e), include hydro-
carbon “staples”,26–28 lactam bridges,29–31 hydrogen-bond surro-
gates,32 photoswitches11,33,34 and triazoles introduced by “click”
chemistry.35–38 The nature of the linker, including anyodhouse Lane, Leeds LS2 9JT, UK. E-mail:
iology, University of Leeds, Woodhouse
n (ESI) available: Synthesis and
and biochemical analyses. See DOI:stereocenters, plays a role in regulating peptide conformation
and target protein aﬃnity.31,39 Introduction of constraints may be
achieved either by intramolecular reaction (Fig. 1a)28,31 or by
chemoselective intermolecular reaction (Fig. 1b) between suit-
ably disposed residues within the peptide sequence and an
appropriate coupling partner.36,40 Introduction of a constraint by
intermolecular reaction, whilst synthetically more demanding,
may be advantageous in that it provides access to functionalized
constraints36 and thus to peptides tailored for biophysical,
cellular and chemical proteomics analyses. Herein, we use BID
and RNase S variant peptides (1a–d) which respectively bind Bcl-
xL proteins41 and RNase S protein42 (Fig. 1f and g), to demonstrate
that dibromomaleimides43–51 serve as versatile constraints that
can be introduced and removed.52–57 These reagents have not
previously been studied for their ability to control peptide hel-
icity. Introduction of an alkyne onto the dibromomaleimide
permits further divergent functionalization by “click” chem-
istry.58 This approach may therefore complement recently re-
ported methods to constrain peptides by reaction of
dichloroacetone59 with side chain thiols and photo-reversible
constraints using S,S0-tetrazine.60
Previously, we14 and others61 introduced a-pentenylglycine as
an alternative to the widely used a,a0-pentenylalanine for cross-
linking the i and i + 4 residues within a peptide (Fig. 1c and d).26
Production of this des-methyl constraint requires a more easilyThis journal is © The Royal Society of Chemistry 2017
Fig. 2 Reversible constraining reaction sequence for peptides 1–3a–
d: conditions for conversion from the oxidised state (OX) through the
intermediate reduced state (RED) to the constrained peptide (STA) and
vice versa (LHS); HRMS analyses of reaction mixture for reversible
interconversion between 1b and 3b (relevant masses are indicated in
black for the peptide and in green for excess glutathione used during
unconstraining) (RHS).
Fig. 1 Overview of peptide stapling strategies and linkers for con-
straining peptides in an a-helical conformation together with struc-
tures for the model protein–protein interactions used in this study; (a)
schematic for intramolecular crosslinking; (b) schematic for intermo-
lecular crosslinking; (c) S,S-a,a0-disubstituted i, i + 4 hydrocarbon
“staple”; (d) S,S-des-methyl i, i + 4 hydrocarbon constraint; (e) i, i + 4
S,S0-maleimide staple reported in this work; (f) and (g) model peptide
sequences 1a–d for BID (1a–b) and RNase S (1c–d) and protein–
protein interactions in this study (Bcl-xL (green)/BID (blue) PDB ID:
4QVE; RNase S protein (green)/S peptide (blue) PDB ID: 1CJQ; hotspot
residues (red)).
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View Article Onlinesynthesized amino acid which is less sterically hindered for
peptide coupling, and, as shown by us, has no deciencies in
terms of biophysical properties when applied to BH3 peptides
BID and BIM.62 We hypothesized that this all hydrocarbon 8-
atom constraint could be replaced with an isoatomic S,S0-mal-
eimide crosslink by reaction of suitably disposed homocysteine
(hCys) residues with dibromomaleimide (or for cysteine (Cys),
a 6-atom constraint) (Fig. 1e).
Peptides 1a–d bearing Cys or hCys amino acids in positions
used previously26,62 for i/ i + 4 constraints were independently
oxidised to the constrained disulde 2a–d or cross-linked with
dibromomaleimide 4 to generate 3a–d with rapid and complete
conversion. Alternatively, this sequence 1a–d to 3a–d could be
performed in one pot and peptides 1a–d fully regenerated by
addition of an excess of thiol (Fig. 2 and S4–7†). It is noteworthy
that conversion of the Cys-derived sequences 1a and 1c to their
constrained derivatives 3a and 3c was more rapid than for the
corresponding hCys derivatives 1b and 1d. It should be noted
that these studies were carried out in unbuﬀered aqueous
solution and future studies will focus on a more detailed anal-
ysis of the reaction rates, their pH dependence and comparison
to other rapid constraining reactions.63 Of further note is theThis journal is © The Royal Society of Chemistry 2017fact that a range of thiols were used including a 10 mM aqueous
solution of glutathione, which corresponds to the average
concentration present in cancer cells.64,65 It may thus be feasible
to harness this approach for controlled delivery of a peptide to
the diseased cell; a focus of future studies. Interestingly,
removal of the maleimide cross-link could be abrogated
through addition of an excess of the reducing agent TCEP,
resulting in a permanent succinimide cross-link (Fig. S9†).
Succinimide linkages of a similar nature have been shown to
undergo thiol mediated cleavage;48 future eﬀorts to “lock” the
constraint may therefore be more appropriately served by
hydrolysis of the imide in the maleimide crosslink.66
Peptides 1a,b and 3a,b were analysed by CD spectroscopy
and subjected to proteolysis assays and uorescence anisotropy
competition assays for inhibition of the BID/Mcl-1, BAK/Bcl-xL
and NOXA-B/Mcl-1 interactions (Fig. 3, S19–23 and S29–30†).
Constrained peptides 3a,b showed no signicant diﬀerence in
helicity (42% and 43%) to each other as a result of the diﬀerent
cross-link length but both were more helical than the corre-
sponding reduced peptide 1a or 1b, (24% and 29%). Molecular
dynamics calculations were conducted on 1b and 3b – these
further support the conclusion that the helical conformation
predominates when constrained by the maleimide linker
(Fig. S25 and S26†). Tryptic proteolysis as monitored by LC-MS14
established that the conformationally constrained peptides 3a,b
exhibit improved proteolytic resistance in comparison to the
reduced peptides 1a,b; proteolysis was retarded up to 7 residues
removed from either side of the thiol residues (Fig. S19–23†).
Taken together these data indicate that the maleimide
constraint confers comparable enhancement of helicity andChem. Sci., 2017, 8, 5166–5171 | 5167
Fig. 3 Analyses on BID derived peptides 1a,b and 3a,b. (a) Circular
dichroism spectra (water/30% acetonitrile); (b) trypsin proteolysis in
a 1 : 10 000 enzyme/substrate ratio (50 mM phosphate buﬀer,
200mMNaCl, pH 7.50); (c) ﬂuorescence anisotropy competition assay
for inhibition of the FITC-BID/Mcl-1 interaction (25 nM tracer, 150 nM
protein, 50 mM Tris buﬀer, 150 mM NaCl, 0.61% of Triton X-100, pH
7.40); (d) ﬂuorescence anisotropy competition assay for inhibition of
the BODIPY-BAK/Bcl-xL interaction (25 nM tracer, 150 nM protein,
50 mM phosphate buﬀer, 200 mM NaCl, 0.02 mg mL1 BSA, pH 7.50).
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View Article Onlineproteolytic resistance to the des-methyl hydrocarbon constraint
reported by us earlier.62 Peptides 1a,b and 3a,b inhibited the
BID/Mcl-1 interaction with comparable potency to the native
WT-BID 8 sequence (IC50  15–25 mM) except for the con-
strained peptide 3b which was slightly more potent (IC50  4.2
mM), thus the constraining/unconstraining reagents have either
a weak or no eﬀect on the inhibitory potency for this PPI.
Although inconsistent with the concept that preorganization
should promote higher binding aﬃnity, the result is consistent
with our own recent studies on hydrocarbon-constrainedFig. 4 (a) Scheme illustrating double click chemistry for generating funct
generate yne-STA-BID-Cys 6, which was further functionalized by click
direct binding assay for interaction of FITC-STA-BID 7b with Mcl-1 and
0.61% of Triton X-100, pH 7.40).
5168 | Chem. Sci., 2017, 8, 5166–5171peptides, which illustrated enthalpy-entropy compensation
operates for these peptides which bind through an induced-t
mechanism.62 For inhibition of BAK/Bcl-xL both constrained
peptides 3a,b were shown to be signicantly superior inhibitors
compared to the reduced peptides 1a,b. The diﬀerential eﬀects
upon potency for the same peptide against Bcl-xL andMcl-1 may
arise as a consequence of favourable non-covalent contacts
between the maleimide and Bcl-xL; it is anticipated that future
structural analyses will shed light on these diﬀerences.
The synthetic method was further adapted to allow the
functionalization of the BID–Cys peptides 7a–c. Using Mitsu-
nobu alkylation,67 alkyne–dibromomaleimide 5 was prepared
and conjugated to peptide 1a to generate the constrained
peptide 6. Without isolation or purication, subsequent “click”
reaction with biotin, uorescein and PEG azides38 aﬀorded
complete conversion to click-conjugated constrained peptides
7a–c (Fig. 4a and b). Related “clickable maleimides” have
previously been used to conjugate small molecule drugs to
polymers,68 whilst “clicked” dibromomaleimides have been
used to conjugate polymers to oxytocin so as to improve solu-
bility.51 Here we have expanded this methodology, demon-
strating that this functionality can be used to constrain peptide
conformation and as a divergent method for peptide function-
alization. The utility of these modications was demonstrated
through a direct uorescence anisotropy titration with the
uorescein linked peptide 7b (Fig. 4c). The observed potencies
are consistent with the EC50 values determined in the compe-
tition assays for 3a,b indicating no detrimental consequence
from the introduction of a uorophore in this position. Such
a modication could thus facilitate cellular studies whilst
leaving the N-terminus of the peptide free to allow further
orthogonal derivatization.
The use of dibromomaleimide-based constraints for
promotion of a-helicity was then further demonstrated using
the RNase S-protein/S-peptide interaction with the choice of
amino acid positions at which to introduce the constraintionalized constrained peptides 7a–c. An alkyne-maleimide was used to
reaction with (b) various azide derivatives. (c) Fluorescence anisotropy
Bcl-xL (75 nM tracer, 15 mM protein, 50 mM Tris buﬀer, 150 mM NaCl,
This journal is © The Royal Society of Chemistry 2017
Fig. 5 Biophysical and bioactivity analyses of WT-S and S derived
peptides 3–4a,c. (a) Circular dichroism spectra recorded in water (30%
TFE); (b) RNA degradation assay showing the restoration of S protein
activity. S protein was used as a negative control, and RNase A as
a positive control. (50 mM Tris, 100 mM NaCl, pH 7.50).
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View Article Onlineinformed by previous studies by the Verdine,26 Hamachi69 and
Dawson59 groups. S peptides 1c and 1d bearing Cys and hCys
residues at the i and i + 4 positions were synthesized using
standard solid-phase synthesis in good yield and puried by
HPLC (Fig. S2 and S3†). Peptides 1c and 1d could not readily be
isolated as reduced bis-thiols; one-pot reduction followed by the
reaction with dibromomaleimide 4 aﬀorded peptides 3c and 3d
(Fig. 2). Both peptides were then analysed by CD spectroscopy
and used in an RNA degradation assay to determine the resto-
ration of enzymatic activity to S-protein in place of the S-peptide
(Fig. 5a and b). In this instance, diﬀerent and more pronounced
behaviour for the Cys and hCys variants was observed, high-
lighting that the eﬀects of introducing a constraint are context-
dependent. The Cys-derived RNase S peptides 2–3c exhibit poor
helicity (e.g. 3c ¼ 9% versus wild-type 8 ¼ 30%) and corre-
sponding low restoration of enzymatic activity (Fig. S31†).
Molecular modelling suggests that the introduction of a disul-
de or a maleimide bridge does not support a helical confor-
mation (Fig. S27 and S28†). In contrast, for the hCys 1–3d series
introduction of a disulde or a maleimide crosslink supports
a helical structure comparable to the WT sequence and
consistent with the moderate eﬀects on helicity for an 8-carbon
constraint in these positions. (Furthermore, and fully consis-
tent with the work of Hamachi and co-workers,69 upon addition
of triuoroethanol (TFE), the constrained peptides reach
a greater overall a-helical content). Here, introduction of
a disulde (2d) or a maleimide (3d) crosslink results in
enhanced helicity in comparison to the WT sequence (2d ¼
56%, 3d ¼ 52% and wild-type 8 ¼ 30%). As a result 3d is much
better able to restore RNase S protein activity than is 3c.
Conclusions
In conclusion, the attractiveness of thiol-based “stapling”
approaches has been recognized for some time,24 but no general
approach has been widely adopted; we have developed a new
method to rapidly and reversibly introduce a functionalized
constraint into two model peptides that enhances a range of
biophysical and biochemical properties. Moreover, the
constraint may be further functionalized in a divergent manner
with motifs useful in chemical biology and proteomicsThis journal is © The Royal Society of Chemistry 2017applications. The approach can be carried out using natural
readily available amino acid side chains on unprotected
peptides, potentially bringing peptide stapling to a larger
community than hitherto have had access and extends the
applications of dibromomaleimide and related reagents. Future
eﬀorts will apply this approach to a wider range of helix medi-
ated PPIs with the aim of establishing the generality of the
method. The approach may also be useful to identify transient
binding pockets proximal to a native ligand binding site using
the template directed approach introduced by Sharpless.70
Similarly, the reversibility of the constraint, may permit more
facile delivery of a peptide-based reagent to the cell, where it can
become unconstrained and less easily transported back out of
the cell. Together with the additional functional handle intro-
duced on the maleimide constraint (which is orthogonal in
terms of its reactivity), this could facilitate detailed cellular and
biochemical analyses e.g. identication of additional targets of
the constrained peptide by pull-down. These objectives will
represent the focus of our future studies.
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